Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer

ABSTRACT: Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer

PROVIDER: PRJNA542169 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9037140_1.fastq.gz	Fastqsanger.gz
	SRR9037140_2.fastq.gz	Fastqsanger.gz
	SRR9037141_1.fastq.gz	Fastqsanger.gz
	SRR9037141_2.fastq.gz	Fastqsanger.gz
	SRR9037142_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 22

Similar Datasets

Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-12-31 | GSE130990 | GEO

Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer.

Project description:Emerging evidence suggests that dysregulation of oncogenic pathways requires precise tuning in order for cancer to develop. To test this, we examined the overlap between cis-acting elements of the hypoxia-inducible factor (HIF) pathway and cancer-susceptibility polymorphisms as defined in genome-wide association studies (GWAS). In renal cancer, where HIF is constitutively and un-physiologically activated by mutation of the von Hippel-Lindau tumour suppressor, we observed marked excess overlap, which extended to potential susceptibility polymorphisms that are below the conventional threshold applied in GWAS. In contrast, in other cancers where HIF is upregulated by different mechanisms, including micro-environmental hypoxia, we observed no excess in overlap. Our findings support a 'pathway tuning' model of cancer, whereby precise modulation of multiple outputs of specific, activated pathways is important in oncogenesis. This implies that selective pressures to modulate such pathways operate during cancer development and should focus attempts to identify their nature and consequences.

| S-EPMC6904466 | biostudies-literature

Ostreococcus tauri strain:RCC 1113 | isolate:RCC 1113 | cultivar:RCC 1113

Project description:Ostreococcus tauri RCC 1113 genome sequencing

| PRJNA337341 | ENA

Ostreococcus tauri strain:RCC 1559 | isolate:RCC 1559 | cultivar:RCC 1559

Project description:Ostreococcus tauri RCC 1559 genome sequencing

| PRJNA337286 | ENA

Ostreococcus tauri strain:RCC 1118 | isolate:RCC 1118 | cultivar:RCC 1118

Project description:Ostreococcus tauri RCC 1118 genome sequencing

| PRJNA337337 | ENA

Ostreococcus tauri strain:RCC 1110 | isolate:RCC 1110 | cultivar:RCC 1110

Project description:Ostreococcus tauri RCC 1110 genome sequencing